Učitavanje...

Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer

SIMPLE SUMMARY: Immunotherapy offers new hope for patients with recurrent or metastatic head and neck cancer. However, only 20% of patients respond to this treatment. Combining radiotherapy in novel ways with immunotherapy can lead to synergistic effect by enabling cancer recognition by immune syste...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Plavc, Gaber, Jesenko, Tanja, Oražem, Miha, Strojan, Primož
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692120/
https://ncbi.nlm.nih.gov/pubmed/33143094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113197
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!